FDA Oks first-line use of travoprost
October 15th 2010Alcon Laboratories announced Sept. 21 that the FDA approved travoprost ophthalmic solution 0.004% formulated with a proprietary ionic-buffered preservative system for first-line treatment to reduce elevated IOP in patients with ocular hypertension or open-angle glaucoma.
Kellogg Eye Center lifts roof on vision
October 15th 2010The newly expanded $132 million Kellogg Eye Center at the University of Michigan, Ann Arbor, boasts 230,000 square feet of clinical and research space across eight floors that house clinics, six operating rooms, research space, and faculty offices.
Research may lead to novel modalities
October 15th 2010Understanding of the physiology of aqueous outflow resistance through the conventional outflow pathway should help to identify new therapeutic targets for IOP lowering and may lead to novel modalities for glaucoma therapy, according to one expert.
Visionary genomics focus of 2011 Association for Research in Vision and Ophthalmology meeting
October 15th 2010Under the theme of "Visionary Genomics," researchers and clinicians will gather at the 2011 annual meeting of the Association for Research in Vision and Ophthalmology in May in Fort Lauderdale, FL, to explore how genomic technology is leading to new understanding of vision health, disease and treatment.
Allergan celebrates 60 years of innovation
October 1st 2010Allergan, the $3 billion multi-specialty health-care company, boasts one of those classic start-up stories that businesses today dream about: Chemist Stanley Bly had an idea for a novel anti-allergy nose drop, so he approached his friend Gavin S. Herbert Sr., who owned a pharmacy and nursed an entrepreneurial spirit.